Neovascular AMD · general population
It is very uncertain whether vitamin E changes neovascular AMD compared with placebo (very low certainty).
1 finding from 1 review
Geographic atrophy · general population
It is very uncertain whether vitamin E changes geographic atrophy compared with placebo (very low certainty).
1 finding from 1 review
Quality of life · general population
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects (AE) · general population
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Resource use and costs · general population
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · children under 5 years of age
1 finding from 1 review
Cause‐specific mortality · children under 5 years of age
1 finding from 1 review
Incidence rate radiologically confirmed first or only episode of pneumonia · children under 5 years of age
1 finding from 1 review
Hospital admissions · children under 5 years of age
1 finding from 1 review
TB cases · children under 5 years of age
1 finding from 1 review
Diarrhoea · children under 5 years of age
1 finding from 1 review
Malaria cases · children under 5 years of age
1 finding from 1 review
Febrile illness · children under 5 years of age
1 finding from 1 review
Any adverse effects of vitamin supplementation sufficient to stop supplementation · pregnant women
Vitamin C and vitamin E showed no clear difference in any adverse effects of vitamin supplementation sufficient to stop… compared with placebo (moderate certainty).
1 finding from 1 review
Vitamin A deficiency · children aged between 6 months and 5 years
Vitamin A supplementation probably leads to lower vitamin A deficiency compared with placebo or usual care (moderate certainty).
1 finding from 1 review
Maternal vitamin D concentration at term (25‐hydroxyvitamin D) (nmol/L) (ALL) · pregnant women
Meta-analysis of randomised trials of vitamin D supplementation for Maternal vitamin D concentrations at term: WMD 47.08 (95% CI 23.76 to 70.39), statistically significant. Umbrella review outcome-level evidence grade: Probable.
1 finding from 1 review
WMD 47.08 [23.76, 70.39]
4 studies
GRADE not reported
All‐cause mortality · ambulatory patients with multiple myeloma receiving immunomodulatory agents
It is very uncertain whether vitamin K antagonist (VKA) changes all‐cause mortality compared with low molecular weight heparin (LMWH) (very low certainty).
2 findings from 1 review
Symptomatic DVT · ambulatory patients with multiple myeloma receiving immunomodulatory agents
It is very uncertain whether vitamin K antagonist (VKA) changes symptomatic deep vein thrombosis compared with low molecular weight heparin (LMWH) (very low certainty).
2 findings from 1 review
Pulmonary embolism · ambulatory patients with multiple myeloma receiving immunomodulatory agents
It is very uncertain whether vitamin K antagonist (VKA) changes pulmonary embolism compared with low molecular weight heparin (LMWH) (very low certainty).
2 findings from 1 review
Major bleeding · ambulatory patients with multiple myeloma receiving immunomodulatory agents
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found